Table 2.
Clinicopathologic characteristics of patients with a preoperative platelet count of <150 x 109/L.
| Variables | Total |
|---|---|
| (n = 17) | |
| Age (years) | 63.1 ±12.5 |
| Gender | |
| Female/male | 8/9 |
| BMI (kg/m2) | 25.08 ± 3.88 |
| ASA score | |
| Class 1 | 0 (0.0%) |
| Class 2 | 8 (57.1%) |
| Class 3 | 6 (42.9%) |
|
| |
| Cirrhosis | |
| Yes | 0 (0.0%) |
| Indication of extended hepatectomy | |
| Benign liver disease | 2 (11.8%) |
| Primary malignancy | 9 (52.9%) |
| Cholangiocarcinoma | 9 (100%) |
| Hepatocellular carcinoma | 0 (0.0%) |
| Metastatic disease | 6 (35.3%) |
| Preoperative chemotherapy | |
| Yes | 5 (29.4%) |
| Preoperative platelet count (x 109/L) | |
| Mean (SD) | 122.3 ± 22.3 |
|
| |
| Intraoperative blood loss (ml) | 3352.94 ± 2019.32 |
| Transfusion of RBC | |
| Patient | 8 (50.0%) |
| Unit | 4.38 ± 6.26 |
| Transfusion of FFP | |
| Patient | 9 (56.3%) |
| Unit | 4.31 ± 5.91 |
| Operation time (min) | 381.29 ± 136.05 |
|
| |
| PHLF a | 10 (58.8%) |
| Grade A | 0 (0.0%) |
| Grade B | 2 (20.0%) |
| Grade C | 8 (80.0%) |
| Major morbidity b | 6 (35.3%) |
| ICU stay (days) | 16.65 ± 9.50 |
| Hospitalization (days) | 30.18 ± 15.20 |
| 30-day mortality | 6 (35.3%) |
BMI: body mass index; ASA: American Society of Anesthesiologists; SD: standard deviation; RBC: red blood cells; FFP: fresh-frozen plasma; PHLF: posthepatectomy liver failure; ICU: intensive care unit.
a Based on the ISGLS definition.
b Grades III and IV based on the Clavien-Dindo classification.